Expect a Limited Role for Basal Insulin/GLP-1 Agonist Combo Products
June 2017
New combo products will raise questions about when to use basal insulin with a GLP-1 agonist for type 2 diabetes.
Combining a GLP-1 agonist (Victoza, etc) and basal insulin (Lantus, etc) may be an alternative to increasing the basal insulin dose...or adding mealtime insulin.
This "insulin-sparing" approach leads to less weight gain than a similar dose of basal insulin alone...with a similar hypoglycemia risk.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote